Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients

Detalhes bibliográficos
Autor(a) principal: Erdem, Fazile Hatipoglu
Data de Publicação: 2010
Outros Autores: Karatay, Saliha, Yildirim, Kadir, Kiziltunc, Ahmet
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/18405
Resumo: OBJECTIVES: The aim of this study was to investigate the activities of serum paraoxonase and arylesterase in patients with ankylosing spondylitis with respect to those of healthy controls, to assess whether these enzyme levels are related to disease activity and functional capacity. METHODS: The study included 32 patients with ankylosing spondylitis whose diagnoses were made according to the modified New York criteria as well as 25 healthy controls matched for age and sex. The Bath Ankylosing Spondylitis Disease Activity Index and the Bath Ankylosing Spondylitis Functional Index were applied to the ankylosing spondylitis patients. As laboratory parameters, the erythrocyte sedimentation rate and serum C-reactive protein level were measured in patients and control subjects. Paraoxonase and arylesterase enzyme activities were measured using appropriate methods. RESULTS: No statistically significant differences (p>;0.05) were found between the ankylosing spondylitis patients and controls in terms of serum paraoxonase or arylesterase levels. Furthermore, there was no correlation between clinical and laboratory parameters in patients with ankylosing spondylitis. CONCLUSION: Serum paraoxonase and arylesterase levels in ankylosing spondylitis patients may not differ from those of healthy controls, and there is no significant correlation between antioxidant parameters and the Bath Ankylosing Spondylitis Disease Activity Index or Bath Ankylosing Spondylitis Functional Index scores in ankylosing spondylitis patients. Further research is needed to provide deeper understanding of this disease.
id USP-19_c6d5cfd72bcbca213a606a4308a4f977
oai_identifier_str oai:revistas.usp.br:article/18405
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients Ankylosing SpondylitisParaoxonaseArylesteraseAntioxidant enzymesOxidative stress OBJECTIVES: The aim of this study was to investigate the activities of serum paraoxonase and arylesterase in patients with ankylosing spondylitis with respect to those of healthy controls, to assess whether these enzyme levels are related to disease activity and functional capacity. METHODS: The study included 32 patients with ankylosing spondylitis whose diagnoses were made according to the modified New York criteria as well as 25 healthy controls matched for age and sex. The Bath Ankylosing Spondylitis Disease Activity Index and the Bath Ankylosing Spondylitis Functional Index were applied to the ankylosing spondylitis patients. As laboratory parameters, the erythrocyte sedimentation rate and serum C-reactive protein level were measured in patients and control subjects. Paraoxonase and arylesterase enzyme activities were measured using appropriate methods. RESULTS: No statistically significant differences (p>;0.05) were found between the ankylosing spondylitis patients and controls in terms of serum paraoxonase or arylesterase levels. Furthermore, there was no correlation between clinical and laboratory parameters in patients with ankylosing spondylitis. CONCLUSION: Serum paraoxonase and arylesterase levels in ankylosing spondylitis patients may not differ from those of healthy controls, and there is no significant correlation between antioxidant parameters and the Bath Ankylosing Spondylitis Disease Activity Index or Bath Ankylosing Spondylitis Functional Index scores in ankylosing spondylitis patients. Further research is needed to provide deeper understanding of this disease. Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2010-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/1840510.1590/S1807-59322010000200009Clinics; Vol. 65 No. 2 (2010); 175-179 Clinics; v. 65 n. 2 (2010); 175-179 Clinics; Vol. 65 Núm. 2 (2010); 175-179 1980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/18405/20468Erdem, Fazile HatipogluKaratay, SalihaYildirim, KadirKiziltunc, Ahmetinfo:eu-repo/semantics/openAccess2012-05-23T11:20:38Zoai:revistas.usp.br:article/18405Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2012-05-23T11:20:38Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients
title Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients
spellingShingle Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients
Erdem, Fazile Hatipoglu
Ankylosing Spondylitis
Paraoxonase
Arylesterase
Antioxidant enzymes
Oxidative stress
title_short Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients
title_full Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients
title_fullStr Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients
title_full_unstemmed Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients
title_sort Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients
author Erdem, Fazile Hatipoglu
author_facet Erdem, Fazile Hatipoglu
Karatay, Saliha
Yildirim, Kadir
Kiziltunc, Ahmet
author_role author
author2 Karatay, Saliha
Yildirim, Kadir
Kiziltunc, Ahmet
author2_role author
author
author
dc.contributor.author.fl_str_mv Erdem, Fazile Hatipoglu
Karatay, Saliha
Yildirim, Kadir
Kiziltunc, Ahmet
dc.subject.por.fl_str_mv Ankylosing Spondylitis
Paraoxonase
Arylesterase
Antioxidant enzymes
Oxidative stress
topic Ankylosing Spondylitis
Paraoxonase
Arylesterase
Antioxidant enzymes
Oxidative stress
description OBJECTIVES: The aim of this study was to investigate the activities of serum paraoxonase and arylesterase in patients with ankylosing spondylitis with respect to those of healthy controls, to assess whether these enzyme levels are related to disease activity and functional capacity. METHODS: The study included 32 patients with ankylosing spondylitis whose diagnoses were made according to the modified New York criteria as well as 25 healthy controls matched for age and sex. The Bath Ankylosing Spondylitis Disease Activity Index and the Bath Ankylosing Spondylitis Functional Index were applied to the ankylosing spondylitis patients. As laboratory parameters, the erythrocyte sedimentation rate and serum C-reactive protein level were measured in patients and control subjects. Paraoxonase and arylesterase enzyme activities were measured using appropriate methods. RESULTS: No statistically significant differences (p>;0.05) were found between the ankylosing spondylitis patients and controls in terms of serum paraoxonase or arylesterase levels. Furthermore, there was no correlation between clinical and laboratory parameters in patients with ankylosing spondylitis. CONCLUSION: Serum paraoxonase and arylesterase levels in ankylosing spondylitis patients may not differ from those of healthy controls, and there is no significant correlation between antioxidant parameters and the Bath Ankylosing Spondylitis Disease Activity Index or Bath Ankylosing Spondylitis Functional Index scores in ankylosing spondylitis patients. Further research is needed to provide deeper understanding of this disease.
publishDate 2010
dc.date.none.fl_str_mv 2010-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/18405
10.1590/S1807-59322010000200009
url https://www.revistas.usp.br/clinics/article/view/18405
identifier_str_mv 10.1590/S1807-59322010000200009
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/18405/20468
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 65 No. 2 (2010); 175-179
Clinics; v. 65 n. 2 (2010); 175-179
Clinics; Vol. 65 Núm. 2 (2010); 175-179
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222755277242368